Indexed metadata
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
Dominique Farge, Séverine Loisel, Matthieu Resche-Rigon, Pauline Lansiaux, Ines Colmegna, David Langlais, Catney Charles, Grégory Pugnet, Alexandre Thibault Jacques Maria, Emmanuel Chatelus, Thierry Martin, Eric Hachulla, Vissal David Kheav, Nathalie C Lambert, HanChen Wang, David Michonneau, Christophe Martinaud, Luc Sensebé, Audrey Cras, Karin Tarte
Source record
Source: Crossref
Published: Feb 1, 2022
DOI: 10.1016/s2665-9913(21)00326-x
Open original source ↗Evidence graph
No public relationships recorded yet.
Integrity note: This page is a factual metadata record created by deterministic ingestion. It is not a claim that the work moves a mathematical frontier or has been independently verified.